Glucoma transplant specialist iStar Medical SA has closed a Series C finanincing round led by LSP and Gimv.
Up To Date
Latest News
Dutch gene therapy company UniQure has launched a US$200m stock offering on Nasdaq.
Polpharma Biologics SA has partnered up with Novartis subsidiary Sandoz AG to market a natalizumab...
German pharma company Boehringer Ingelheim said the phase II trial for candidate drug BI456906 is expected to...
Results presented at European Society of Cardiology Congress 2019 demonstrate a new disease mechanism...
A US-EU research team has found that a class of compounds that promote tumour cell death can also limit...
Share
